Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Dec 27, 2021; 13(12): 1685-1695
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1685
Table 2 Comparisons of the perioperative variables between two groups (n = 62)
VariablesNo. (%) or mean ± SD

Massive-lesion, n = 24
Smaller-lesion, n = 38
P value
Age, yr36.6 ± 13.539.3 ± 11.80.426
BMI, kg/m222.8 ± 3.122.7 ± 2.80.07
Type 2 diabetes mellitus0.289
Yes3 (12.5)1 (2.6)
No21 (87.5)37 (97.4)
Hypertension0.927
Yes4 (16.7)6 (15.8)
No20 (83.3)32 (84.2)
ASA classification0.678
Class I17 (70.8)25 (65.8)
Class II7 (29.1)13 (34.2)
Previous abdominal surgery0.660
Yes14 (58.3)20 (52.6)
No10 (41.7)18 (47.4)
Previous treatment0.027a
Yes7 (29.2)3 (7.9)
No17 (70.8)35 (92.1)
Symptomatic0.416
Yes12 (50.0)15 (39.5)
No12 (50.0)23 (60.5)
Digital rectal examination0.924
Positive20 (83.3)30 (78.9)
Negative4 (16.6)8 (21.1)
Tumor location0.258
Above-S313 (54.2)26 (68.4)
Under-S311 (45.8)12 (31.6)
Tumor size, cm11.5 ± 2.36.2 ± 1.50.000a
Operation duration, min183.6 ± 57.5104.7 ± 43.70.000a
Blood loss, mL117.1 ± 175.730.3 ± 36.70.004a
Perioperative complications0.027a
Yes17 (70.8)16 (42.1)
No7 (29.2)22 (57.9)
Severe complicationsa0.022a
Yes6 (25.0)1 (2.6)
No18 (75.0)37 (97.4)
Postoperative length of hospital stay,d7.7 ± 4.66.3 ± 2.90.111
Readmission within 90 d0.019a
Yes4 (16.6)0 (0.0)
No20 (83.3)38 (100.0)